Evidence map›Paper›PMID 20613527›Full record

ReviewCurrent opinion in organ transplantation2010

Alloimmunity and autoimmunity in chronic rejection.

Anil Seetharam, Venkataswarup Tiriveedhi, T Mohanakumar

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in organ transplantation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Hashimoto's thyroiditis and renal transplant rejection.Journal of endocrinological investigation · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Facial and hand allotransplantation.Cold Spring Harbor perspectives in medicine · 2014
    Review
  10. Review
  11. Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2013
    Article
  12. B-lymphocyte lineage cells and the respiratory system.The Journal of allergy and clinical immunology · 2013
    Review
  13. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2012
    Article
  14. T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2012
    Article
  15. Review
  16. Article
  17. Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2012
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Anil SeetharamDivision of Gastroenterology, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
Venkataswarup Tiriveedhi
T Mohanakumar
GTx (United States) · USUniversity Gastroenterology · USUniversity Surgical Associates · US

Funding

IMMUNE MECHANISMS OF REJECTION IN HUMAN LUNG ALLOGRAFTSR01HL056643 · NHLBI · WASHINGTON UNIVERSITY · PI MOHANAKUMAR, THALACHALLOUR · 1996 to 2015
$6.5M
ALLOANTIBODIES TO MHC INDUCES AUTOIMMUNITY AND OBLITERATIVE AIRWAY DISEASE (OAD)R01HL092514 · NHLBI · WASHINGTON UNIVERSITY · PI MOHANAKUMAR, THALACHALLOUR · 2009 to 2018
$3.0M
PATHOGENESIS OF POST-TRANSPLANT BRONCHIOLITIS OBLITERANSR01HL066452 · NHLBI · WASHINGTON UNIVERSITY · PI MOHANAKUMAR, THALACHALLOUR · 2001 to 2004
$1.2M
Pathogenesis of Post-Transplant Bronchiolitis ObliteransR56HL066452 · NHLBI · WASHINGTON UNIVERSITY · PI MOHANAKUMAR, THALACHALLOUR · 2008 to 2008
$380k
NHLBI NIH HHS HL056643NHLBI NIH HHS HL092514NHLBI NIH HHS HL66452NHLBI NIH HHS R01 HL056643NHLBI NIH HHS R01 HL066452NHLBI NIH HHS R01 HL092514NHLBI NIH HHS R56 HL066452
6 · The paper itself

Abstract

purpose of reviewRecent studies demonstrate an increasing role for alloimmune responses in the disruption of self-tolerance leading to immune responses to self-antigens that play a role in the immunopathogenesis of chronic rejection following solid organ transplantation. This review summarizes recent studies and implications for the alloimmune-response-induced de-novo development of autoimmune responses following solid organ transplantations. RECENT

findingsImmediately following organ transplantation, several factors lead to enduring an inflammatory milieu. Studies from our laboratory and others have demonstrated that development of antihuman leukocyte antigen antibodies precedes the development of chronic rejection. Using an in-vivo murine model, we have demonstrated that administration of anti-major histocompatibility complex (MHC) class I directly into the native lungs leads to chronic rejection pathology. Further, the in-vitro ligation of epithelial cell surface MHC class I molecules by specific anti-MHC can lead to cell activation and production of fibrinogenic growth factors. SUMMARY: On the basis of these findings, we hypothesized that alloimmune responses can lead to autoimmunity, thus playing an important role in chronic rejection. Characterization of both the temporal occurrence and functional significance of antibodies to self-antigens may provide insight into the pathogenesis of chronic rejection and these antibodies can serve as clinically useful biomarkers.

Indexed as

AutoimmunityGraft SurvivalTransplantation ToleranceAnimalsChronic DiseaseGraft RejectionHumansImmunity, CellularImmunity, HumoralImmunosuppression TherapyInflammation MediatorsOrgan TransplantationTransplantation, HomologousTreatment OutcomeInflammation Mediators

Identifiers

PMID20613527
PMCPMC2926928
OpenAlexW2018043519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.